These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 24095053)

  • 1. Ergosterol peroxide from Cordyceps cicadae ameliorates TGF-β1-induced activation of kidney fibroblasts.
    Zhu R; Zheng R; Deng Y; Chen Y; Zhang S
    Phytomedicine; 2014 Feb; 21(3):372-8. PubMed ID: 24095053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emodin inhibits extracellular matrix synthesis by suppressing p38 and ERK1/2 pathways in TGF-β1-stimulated NRK-49F cells.
    Zhu B; Lin Y; Zhu CF; Zhu XL; Huang CZ; Lu Y; Cheng XX; Wang YJ
    Mol Med Rep; 2011; 4(3):505-9. PubMed ID: 21468599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prohibitin suppresses renal interstitial fibroblasts proliferation and phenotypic change induced by transforming growth factor-beta1].
    Guo W; Xu H; Huang WY; Chen J; Yang Y; Fu R; Liu HM; Zha XL; Zhang ZG
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1660-5. PubMed ID: 17825142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gefitinib attenuates transforming growth factor-β1-activated mitogen-activated protein kinases and mitogenesis in NRK-49F cells.
    Chen SC; Guh JY; Lin TD; Chiou SJ; Hwang CC; Ko YM; Chuang LY
    Transl Res; 2011 Oct; 158(4):214-24. PubMed ID: 21925118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apigenin Alleviates Renal Fibroblast Activation through AMPK and ERK Signaling Pathways
    Li N; Wang Z; Sun T; Lei Y; Liu X; Li Z
    Curr Pharm Biotechnol; 2020; 21(11):1107-1118. PubMed ID: 32196447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lefty-1 alleviates TGF-β1-induced fibroblast-myofibroblast transdifferentiation in NRK-49F cells.
    Zhang L; Zhang J; Xu C; Zhou X; Wang W; Zheng R; Hu W; Wu P
    Drug Des Devel Ther; 2015; 9():4669-78. PubMed ID: 26316705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astragaloside IV inhibits renal tubulointerstitial fibrosis by blocking TGF-β/Smad signaling pathway in vivo and in vitro.
    Wang L; Chi YF; Yuan ZT; Zhou WC; Yin PH; Zhang XM; Peng W; Cai H
    Exp Biol Med (Maywood); 2014 Oct; 239(10):1310-24. PubMed ID: 24879422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sanqi oral solution ameliorates renal fibrosis by suppressing fibroblast activation via HIF-1α/PKM2/glycolysis pathway in chronic kidney disease.
    Hu D; Wang L; Zhang Y; Liu X; Lu Z; Li H
    J Ethnopharmacol; 2024 Dec; 335():118679. PubMed ID: 39121930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifibrotic role of PGC-1α-siRNA against TGF-β1-induced renal interstitial fibrosis.
    Wang JL; Chen CW; Tsai MR; Liu SF; Hung TJ; Yu-Ju-Hung ; Chang WT; Shi MD; Hsieh PF; Yang YL
    Exp Cell Res; 2018 Sep; 370(1):160-167. PubMed ID: 29913155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: a potential target for preventing renal fibrosis.
    Yokoi H; Sugawara A; Mukoyama M; Mori K; Makino H; Suganami T; Nagae T; Yahata K; Fujinaga Y; Tanaka I; Nakao K
    Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S134-8. PubMed ID: 11576939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts.
    Gu J; Liu X; Wang QX; Tan HW; Guo M; Jiang WF; Zhou L
    Exp Cell Res; 2012 Oct; 318(16):2105-15. PubMed ID: 22749815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-β(1)-induced fibroblast activation.
    Yuan Q; Wang R; Peng Y; Fu X; Wang W; Wang L; Zhang F; Peng Z; Ning W; Hu G; Wang Z; Tao L
    Am J Nephrol; 2011; 34(2):181-94. PubMed ID: 21791914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of AMPK by metformin inhibits TGF-β-induced collagen production in mouse renal fibroblasts.
    Lu J; Shi J; Li M; Gui B; Fu R; Yao G; Duan Z; Lv Z; Yang Y; Chen Z; Jia L; Tian L
    Life Sci; 2015 Apr; 127():59-65. PubMed ID: 25744403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WISP3 prevents fibroblast-myofibroblast transdifferentiation in NRK-49F cells.
    Yi Y; Ma J; Jianrao L; Wang H; Zhao Y
    Biomed Pharmacother; 2018 Mar; 99():306-312. PubMed ID: 29353205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin ameliorates renal fibrosis by inhibiting local fibroblast proliferation and extracellular matrix deposition.
    Zhou X; Zhang J; Xu C; Wang W
    J Pharmacol Sci; 2014; 126(4):344-50. PubMed ID: 25452269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of spleen tyrosine kinase (syk) suppresses renal fibrosis through anti-inflammatory effects and down regulation of the MAPK-p38 pathway.
    Chen KH; Hsu HH; Yang HY; Tian YC; Ko YC; Yang CW; Hung CC
    Int J Biochem Cell Biol; 2016 May; 74():135-44. PubMed ID: 26948651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fuzheng Huayu recipe and vitamin E reverse renal interstitial fibrosis through counteracting TGF-beta1-induced epithelial-to-mesenchymal transition.
    Wang QL; Yuan JL; Tao YY; Zhang Y; Liu P; Liu CH
    J Ethnopharmacol; 2010 Feb; 127(3):631-40. PubMed ID: 20015471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor ataxia telangiectasia mutated functions downstream of TGF-β1 in orchestrating profibrotic responses.
    Overstreet JM; Samarakoon R; Cardona-Grau D; Goldschmeding R; Higgins PJ
    FASEB J; 2015 Apr; 29(4):1258-68. PubMed ID: 25480384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kruppel-like factor 15 modulates renal interstitial fibrosis by ERK/MAPK and JNK/MAPK pathways regulation.
    Gao X; Wu G; Gu X; Fu L; Mei C
    Kidney Blood Press Res; 2013; 37(6):631-40. PubMed ID: 24356553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide inhibits fibronectin production in TGF-β1-treated normal and keloid fibroblasts via inhibition of the p38/Smad3 pathway.
    Liang CJ; Yen YH; Hung LY; Wang SH; Pu CM; Chien HF; Tsai JS; Lee CW; Yen FL; Chen YL
    Biochem Pharmacol; 2013 Jun; 85(11):1594-602. PubMed ID: 23500539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.